Guobang Pharma Ltd. News

Investor Relations Activity Record Form

Nov 20 17:48

Guobang Pharmaceutical\'s announcement on holding a performance briefing for the third quarter of 2024

Oct 23 00:00

Guobang Pharmaceutical\'s announcement on holding the 2024 semi-annual results briefing

Sep 12 00:00

Guobang Pharmaceutical: Investor Relations Activity Record Form for August 30, 2024 (Performance Briefing)

Sep 2 15:58

Guobang Pharmaceutical\'s special report on the storage and use of funds raised for the first half year of 2024

Aug 30 00:00

Announcement of Resolutions of the 9th Meeting of the 2nd Board of Directors of Guobang Pharmaceutical

Aug 30 00:00

Announcement of Resolutions of the Eighth Meeting of the 2nd Board of Supervisors of Guobang Pharmaceutical

Aug 30 00:00

Announcement of Resolutions of the 8th Meeting of the Second Board of Directors of Guobang Pharmaceutical

Jun 28 00:00

Management Measures for the First Phase of Country Union Pharmacy Employee Stock Ownership Plan.

Jun 28 00:00

Independent financial advisor report on the first employee stock ownership plan (draft) of Guobang Pharmaceutical Group Co., Ltd. from Rongzheng Enterprise Consulting Services (Group) Co., Ltd. Shanghai.

Jun 28 00:00

Legal Opinion of Guohao Law Firm (Hangzhou) on the First Phase Employee Stock Ownership Plan of Guobang Pharmaceutical Group Co., Ltd.

Jun 28 00:00

Verification opinion on the first phase of the company's employee shareholding plan by Guobang Pharmaceutical's supervisors.

Jun 28 00:00

Announcement of the resolution of the 7th meeting of the 2nd Board of Supervisors of Guobang Pharmaceutical

Jun 28 00:00

Special Legal Opinion of Guohao Law Firm (Hangzhou) on the Differential Dividend of Guobang Medicine

Jun 7 00:00

Verification opinions of Guotai Junan Securities Co., Ltd. on the completion of Guobang Pharmaceutical Group Co., Ltd.\'s fund-raising project and permanently replenish working capital with savings raised

Apr 16 00:00

Guobang Pharmaceutical\'s announcement on the estimated amount of guarantee provided to subsidiaries in 2024

Apr 16 00:00

Guobang Pharmaceutical\'s Feasibility Analysis Report on Launching Foreign Exchange Hedging Business

Apr 16 00:00

Guobang Pharmaceutical\'s announcement on changes in accounting policies

Apr 16 00:00

Lixin Certified Public Accountants on Guobang Pharmaceutical\'s 2023 Audit Report and Financial Statement

Apr 16 00:00

Announcement of Resolutions of the 6th Meeting of the 2nd Board of Supervisors of Guobang Pharmaceutical

Apr 16 00:00